BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15.08.2025

Advancing the Development of Interchangeable Products: Identifying Future Needs; Public Workshop; Request for Comments

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Advancing the Development of Interchangeable Products: Identifying Future Needs." The purpose of the public workshop is to address a commitment FDA made in the Biosimilar User Fee Act (BsUFA) reauthorization commitment letter for fiscal years (FYs) 2023 through 2027 (BsUFA III) to hold a scientific workshop to discuss and identify future needs (e.g., guidance, research) that, when addressed, may help further advance the development of interchangeable biosimilar products.

Source: Federal Register — Food and Drug AdministrationOpen original release →